FDA regulators GE Healthcare’s latest high-def, low-dose CT scanner, which the company calls the 1st that’s “right for physicians in every clinical specialty.” GE Healthcare’s (NYSE:GE) this week touted a new FDA win for its latest in CT scanner technology, saying the Revolution* CT^ is the 1st of its kind that’s right for “every clinical specialty.” The healthcare giant landed 510(k) clearance to market the device as an all-in-one CT scanner for cardiology, oncology and neurology, saying the sedation-free imaging technology could play an important role for “sensitive” patient groups, such as pediatric, renal insufficiency, trauma and stroke patients.
Help employers find you! Check out all the jobs and post your resume.
